Abiopharma

(10% Negative) Eagle Pharmaceuticals, Inc. (EGRX) Announces Delay in agreement Trials for our company Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(70% Positive) BELLUS Health Inc (the company became a subdivision of the company GSK (NYSE: GSK)) (BLU) Files Form 6-K

(99% Neutral) Affimed NV (AFMD) Files Form 6-K

(98% Neutral) HUTCHMED DRC (HCM) Announces Clinical Development Update (Form 6-K)

(99% Neutral) MERUS N.V. (MRUS) Announces Regulatory Update

(99% Neutral) NRX PHARMACEUTICALS, INC. (NRXP) Announces Enrollment Update for protocols Due to Pandemic-Related Challenges, Patient Enrollment Issues, Safety Review

(99% Neutral) RAPT Therapeutics, Inc. (RAPT) Provides Update on jurisdiction for which such offer

(35% Negative) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update

(50% Neutral) ZENTALIS PHARMACEUTICALS, INC. (ZNTL) Announces New Board Appointment

(99% Neutral) BIOMARIN PHARMACEUTICAL INC (BMRN) Announces Regulatory Update